Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: A case report [11]

Leukemia and Lymphoma

Volumn 48, Issue 6, 2007, Pages 1247-1249

  Cil, Timucin ^a,b   Kaplan, M Ali ^a   Altintas, Abdullah ^a,b   Pasa, Semir ^a,b   Isikdogan, Abdurrahman ^a,b  

^a Department of Hematology Oncology ^*  (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CD20 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; B LYMPHOCYTE; BLOOD PRESSURE; BODY TEMPERATURE; BRADYCARDIA; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPHADENOPATHY; DIZZINESS; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; HEART EJECTION FRACTION; HISTOPATHOLOGY; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PULSE RATE; PULSE WAVE; QT INTERVAL; SINUS RHYTHM;

ANTIMETABOLITES, ANTINEOPLASTIC; BRADYCARDIA; CYTARABINE; ELECTROCARDIOGRAPHY; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED;

EID: 34347326122     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701332456     Document Type: Letter

References (12)

1. Kumar, S., Noronha, V. and Chu, E. (2005) Pharmacology of cancer chemotherapy. Cancer: Principles & Practice of Oncology, p. 366. Lippincott Williams & Wilkins, Philadelphia
2. Conrad, M. E. (1992) Cytarabine and cardiac failure. Am J Hematol, 41, pp. 143-144.
3. Willemze, R., Zwaan, F. E., Colpin, G. and Keuning, J. J. (1982) High dose cytosine arabinoside in the management of refractory acute leukaemia. Scand J Haematol, 29, pp. 141-146.
4. Vaickus, L. and Letendre, L. (1984) Pericarditis induced by high-dose cytarabine therapy. Arch Intern Med, 144, pp. 1868-1869.
5. Reykdal, S., Sham, R. and Kouides, P. (1995) Cytarabine-induced pericarditis: A case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy. Leuk Res, 19, pp. 141-144.
6. Hermans, C., Straetmans, N., Michaux, J. L. and Ferrant, A. (1997) Pericarditis induced by high-dose cytosine arabinoside chemotherapy. Ann Hematol, 75, pp. 55-57.
7. Stamatopoulos, K., Kanellopoulou, G., Vaiopoulos, G., Stamatellos, G. and Yataganas, X. (1998) Evidence for sinoatrial blockade associated with high dose cytarabine therapy. Leuk Res, 22, pp. 759-761.
8. Yamada, T., Tsurumi, H., Hara, T., Sawada, M., Oyama, M. and Moriwaki, H. (1998) Cytarabine-induced pericarditis. Rinsho Ketsueki, 39, pp. 1115-1120.
9. Gahler, A., Hitz, F., Hess, U. and Cerny, T. (2003) Acute pericarditis and pleural effusion complicating cytarabine chemotherapy. Onkologie, 26, pp. 348-350.
10. Kumagawa, M., Suzuki, K., Nagano, M., Takamatsu, Y., Suzumiya, J. and Tamura, K. (2003) High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16) (p13q22). Rinsho Ketsueki, 44, pp. 404-406.
11. Floyd, J. D., Nguyen, D. T., Lobins, R. L., Bashir, Q., Doll, D. C. and Perry, M. C. (2005) Cardiotoxicity of cancer therapy. J Clin Oncol, 23, pp. 7685-7696.
12. Pai, V. B. and Nahata, M. C. (2000) Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention. Drug Saf, 22, pp. 263-302.